What is the size of the Asia-Pacific Active Pharmaceutical Ingredient market in 2023?

The Asia-Pacific Active Pharmaceutical Ingredient market size is USD 82.6 billion in 2023.

What is the projected CAGR at which the Asia-Pacific Active Pharmaceutical Ingredient market is expected to grow at?

The Asia-Pacific Active Pharmaceutical Ingredient market is expected to grow at a CAGR of 8.7% (2024-2033).

List the segments encompassed in this report on the Asia-Pacific Active Pharmaceutical Ingredient market?

Market.US has segmented the Asia-Pacific Active Pharmaceutical Ingredient market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type the market has been segmented into Generic, Innovative), By Manufacturers (Captive, Merchant), By Synthesis (Biotech, Synthetic), By Usage (Clinical, Research), By Application (Cardiology, Oncology, Neurology, Orthopedics, Endocrinology, Pulmonology, Nephrology, Ophthalmology, Others).

List the key industry players of the Asia-Pacific Active Pharmaceutical Ingredient market?

Sun Pharmaceuticals, Dr. Reddy’s Laboratories, Aurobindo Pharma, Syn-Tech Chem & Pharm Co. Ltd., Everlight Chemical Industrial Corporation, Yung Shin Pharma Ind.Co. Ltd, Meiji, API Corporation, SK Bioland, Anzchem, Auspep

Which region is more appealing for vendors employed in the Asia-Pacific Active Pharmaceutical Ingredient market?

China is expected to account for the highest revenue share of 41.2% and boasting an impressive market value of USD 34 billion. Therefore, the Asia-Pacific Active Pharmaceutical Ingredient industry in North America is expected to garner significant business opportunities over the forecast period.

Asia-Pacific Active Pharmaceutical Ingredient Market Analysis By Type (Generic, Innovative), By Manufacturers (Captive, Merchant), By Synthesis (Biotech, Synthetic), By Usage (Clinical, Research), By Application (Cardiology, Oncology, Neurology, Orthopedics, Endocrinology, Pulmonology, Nephrology, Ophthalmology, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: March 2024
Report ID: 74488
Number of Pages: 245
Format:

- Sun Pharmaceuticals
- Dr. Reddys Laboratories Ltd Company Profile
- Aurobindo Pharma
- Syn-Tech Chem & Pharm Co. Ltd.
- Everlight Chemical Industrial Corporation
- Yung Shin Pharma Ind.Co. Ltd
- Meiji
- API Corporation
- SK Bioland
- Anzchem
- Auspep

Related Reports

Our Clients

Asia-Pacific Active Pharmaceutical Ingredient Market

Report ID 74488
Published Date March 2024
Rating
- ★★★★★
  
  ★★★★★
- (104)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible